Symbol
PTIX on Nasdaq
Investment type
Equity - Shares of Stock
Class
Common Stock, par value $0.0001
Latest Disclosed Ownership
240K shares
Security Ownership
3.41%

Armistice Capital, LLC ownership in Protagenic Therapeutics, Inc.new Common Stock, par value $0.0001 (PTIX)

2025-02-14 - Armistice Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 240K shares of Protagenic Therapeutics, Inc.new Common Stock, par value $0.0001 (PTIX). This represents 3.41% percent ownership of the company.